Nagma: Building an IVF Portfolio Is Not Just About Adding More Tests…
Nagma, Deputy Manager of Product Marketing at Max Lab, shared on LinkedIn:
“Building an IVF portfolio is not just about adding more tests. It’s about understanding where diagnostics can create value across the fertility journey.
From preconception and hormonal assessment to male fertility, genetic testing and reproductive health, IVF involves multiple clinical touchpoints, each with distinct diagnostic needs.
As a Product Manager, the opportunity is to look beyond individual tests and ask:
- What are the key clinical gaps?
- What do fertility specialists need at each stage?
- Which diagnostic solutions can support better clinical decisions?
- And where can we create sustainable business growth?
A strong IVF portfolio brings together clinical relevance, specialist needs, patient value and business opportunity.
For me, the focus is simple:
Not more tests. Better solutions for the right clinical need, at the right stage of the fertility journey.”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic